The world’s Largest Sharp Brain Virtual Experts Marketplace Just a click Away
Levels Tought:
University
| Teaching Since: | Apr 2017 |
| Last Sign in: | 438 Weeks Ago, 1 Day Ago |
| Questions Answered: | 9562 |
| Tutorials Posted: | 9559 |
bachelor in business administration
Polytechnic State University Sanluis
Jan-2006 - Nov-2010
CPA
Polytechnic State University
Jan-2012 - Nov-2016
Professor
Harvard Square Academy (HS2)
Mar-2012 - Present
2.14 As noted in this chapter, many generic versions of the diabetes drug Glucophage were introduced within the first year of Glucophage’s patent expiration. Recently, the U.S. Supreme Court ruled that patients who become ill taking generic drugs cannot sue the manufacturer of those drugs, even though: “People who are hurt by a brand-name drug can sue the drug maker for damages.” How might the Supreme Court’s decision affect the willingness of pharmaceutical firms to invest in research and development on new drugs?
-----------